BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/30/2024 2:06:38 PM | Browse: 72 | Download: 31
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Real-world evidence on the efficacy and safety of vonoprazan-amoxicillin dual therapy for Helicobacter pylori treatment in elderly patients
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Wen Gao, Jing-Wen Li, Hui Ye, Xue-Zhi Zhang, Jian-Xiang Liu and Hong Cheng |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National High Level Hospital Clinical Research Funding (Youth Clinical Research Project of Peking University First Hospital) |
2023YC27 |
Capital’s Funds for Health Improvement and Research |
2022-2-40711 |
National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital) |
2024IR20 |
|
Corresponding Author |
Hong Cheng, MD, Professor, Department of Gastroenterology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing 100034, China. chenghong1969@163.com |
Key Words |
Helicobacter pylori; Vonoprazan; Amoxicillin; Dual therapy; Elderly |
Core Tip |
Vonoprazan-amoxicillin (VA) dual treatment is as effective as traditional bismuth-based quadruple therapy for the eradication of Helicobacter pylori (H. pylori) in the general population. However, the safety of this regimen in the elderly population is unknown. This real-world study retrospectively analyzed data from elderly patients treated for H. pylori infection. VA dual therapy demonstrated good safety and efficacy in the elderly patients with an eradication rate similar to that of the general population. The findings provided evidence supporting the use of VA dual therapy in elderly patients. |
Citation |
Gao W, Li JW, Ye H, Zhang XZ, Liu JX, Cheng H. Real-world evidence on the efficacy and safety of vonoprazan-amoxicillin dual therapy for Helicobacter pylori treatment in elderly patients. World J Gastroenterol 2024; In press |
|
Received |
|
2024-09-15 14:14 |
|
Peer-Review Started |
|
2024-09-15 14:14 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-27 19:29 |
|
Revised |
|
2024-10-07 15:28 |
|
Second Decision |
|
2024-10-30 02:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-10-30 14:06 |
|
Articles in Press |
|
2024-10-30 14:06 |
|
Publication Fee Transferred |
|
2024-10-30 14:29 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345